Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Angelberger

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphyS Li, M Peck-Radosavljevic, O Kienast, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cellsB J Fueger, G Hamilton, M Raderer, et al.
Life Sciences|March 10, 2001
Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cellsS R Li, E Koller, P Valent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbuminA Kurtaran, C Müller, G Novacek, et al.
Journal of Neural Transmission. General Section|January 1, 1995
beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivoW Pirker, S Asenbaum, S Kasper, et al.
European Journal of Nuclear Medicine|April 1, 1997
Monitoring of the biodistribution and biokinetics of dysprosium-165 ferric hydroxide with a shadow-shield whole-body counterC Pirich, U Prüfert, E Havlik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Vasoactive intestinal peptide receptor scintigraphyI Virgolini, A Kurtaran, M Raderer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1993
The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancerT Leitha, S Meghdadi, M Studnicka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomasA Kurtaran, S R Li, M Raderer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinomaM Leimer, A Kurtaran, P Smith-Jones, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphyS Li, M Peck-Radosavljevic, O Kienast, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cellsB J Fueger, G Hamilton, M Raderer, et al.
Life Sciences|March 10, 2001
Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cellsS R Li, E Koller, P Valent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbuminA Kurtaran, C Müller, G Novacek, et al.
Journal of Neural Transmission. General Section|January 1, 1995
beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivoW Pirker, S Asenbaum, S Kasper, et al.
European Journal of Nuclear Medicine|April 1, 1997
Monitoring of the biodistribution and biokinetics of dysprosium-165 ferric hydroxide with a shadow-shield whole-body counterC Pirich, U Prüfert, E Havlik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Vasoactive intestinal peptide receptor scintigraphyI Virgolini, A Kurtaran, M Raderer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1993
The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancerT Leitha, S Meghdadi, M Studnicka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomasA Kurtaran, S R Li, M Raderer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinomaM Leimer, A Kurtaran, P Smith-Jones, et al.
Pageof 11